SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Aligos Therapeutics, Inc. ALGS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Aligos Therapeutics, Inc. (ALGS) 有 8 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ACHL, ASMB, CTMX, NLTX, NUVB, NXTC 等.

ALGS 的市值为 $52.91M, 而同行平均市值为 $405.29M. ALGS 显著小于其平均同行.

同行与相似公司 — ALGS

Achilles Therapeutics plc

$1.48 +0.68% $60.83M

Assembly Biosciences, Inc.

$29.44 +0.68% $467M

CytomX Therapeutics, Inc.

$4.54 +3.42% $772.94M

Neoleukin Therapeutics, Inc.

$3.49 +1.45% $8.2M

Nuvation Bio Inc.

$4.85 +3.19% $1.68B

$12.77 +3.65% $34.22M

Spero Therapeutics, Inc.

$2.78 -0.36% $160.94M

Instil Bio, Inc.

$8.44 +1.02% $57.24M

其他人也在看

Nuvation Bio Inc.

CytomX Therapeutics, Inc.

Assembly Biosciences, Inc.

Spero Therapeutics, Inc.

Achilles Therapeutics plc

Instil Bio, Inc.

Neoleukin Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言